Find Clomethiazole manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 533-45-9, Chlormethiazole, 5-(2-chloroethyl)-4-methylthiazole, Distraneurin, 5-(2-chloroethyl)-4-methyl-1,3-thiazole, Chlorethiazol
Molecular Formula
C6H8ClNS
Molecular Weight
161.65  g/mol
InChI Key
PCLITLDOTJTVDJ-UHFFFAOYSA-N
FDA UNII
0C5DBZ19HV

Clomethiazole
A sedative and anticonvulsant often used in the treatment of alcohol withdrawal. Chlormethiazole has also been proposed as a neuroprotective agent. The mechanism of its therapeutic activity is not entirely clear, but it does potentiate GAMMA-AMINOBUTYRIC ACID receptors response and it may also affect glycine receptors.
1 2D Structure

Clomethiazole

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-(2-chloroethyl)-4-methyl-1,3-thiazole
2.1.2 InChI
InChI=1S/C6H8ClNS/c1-5-6(2-3-7)9-4-8-5/h4H,2-3H2,1H3
2.1.3 InChI Key
PCLITLDOTJTVDJ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C(SC=N1)CCCl
2.2 Other Identifiers
2.2.1 UNII
0C5DBZ19HV
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Chlormethiazole

2. Distraneurin

2.3.2 Depositor-Supplied Synonyms

1. 533-45-9

2. Chlormethiazole

3. 5-(2-chloroethyl)-4-methylthiazole

4. Distraneurin

5. 5-(2-chloroethyl)-4-methyl-1,3-thiazole

6. Chlorethiazol

7. Chlormethiazol

8. Clomethiazolum

9. Emineurina

10. Somnevrin

11. Thiazole, 5-(2-chloroethyl)-4-methyl-

12. Clomethiazole [inn]

13. Chloro-s.c.t.z.

14. Distraneurine

15. Wy 1485

16. Sctz [as Edisylate]

17. 0c5dbz19hv

18. Chlorethiazole

19. Clomethiazole (inn)

20. Ncgc00024842-02

21. Clometiazole

22. Dsstox_cid_2842

23. C6h8clns

24. Dsstox_rid_76753

25. Dsstox_gsid_22842

26. Clometiazolo [dcit]

27. Chloraethiazol

28. Clometiazol

29. Clometiazolo

30. Clometiazol [inn-spanish]

31. Clomethiazolum [inn-latin]

32. Cas-533-45-9

33. Einecs 208-565-7

34. Clomethiazole [inn:ban]

35. Unii-0c5dbz19hv

36. 4-methyl-5-(beta-chloroethyl)thiazole

37. Brn 0114244

38. Distraneurine (tn)

39. Sctz (salt/mix)

40. Tocris-0881

41. Heminevrin (salt/mix)

42. Clomethiazole [mi]

43. Biomol-nt_000260

44. Schembl35223

45. 4-27-00-00990 (beilstein Handbook Reference)

46. Mls004754487

47. Clomethiazole [mart.]

48. Clomethiazole [who-dd]

49. Bpbio1_000815

50. Chembl315795

51. Zinc1192

52. Dtxsid6022842

53. Chebi:92875

54. Bdbm234400

55. Clomethiazole [nflis-drug]

56. Tox21_110931

57. Mfcd00868012

58. 4-methyl-5-(2-chloroethyl)-thiazole

59. Akos011348416

60. Tox21_110931_1

61. Ab07565

62. Db06470

63. Sdccgsbi-0633688.p001

64. 5-(2-chloro-ethyl)-4-methyl-thiazole

65. Ncgc00024842-01

66. Ncgc00024842-03

67. Ncgc00024842-04

68. Ncgc00024842-05

69. 4-methyl-5-(.beta.-chloroethyl)thiazole

70. Ac-33175

71. As-13864

72. Smr002529479

73. Db-071667

74. Hy-129105

75. Cs-0103601

76. Ft-0659713

77. En300-60459

78. 33c459

79. 5-(2-chloroethyl)-4-methyl-1,3-thiazole #

80. D07330

81. Q417178

82. W-203012

83. Brd-k50422030-001-01-2

84. Brd-k50422030-003-01-8

85. Z1259086813

2.4 Create Date
2005-03-27
3 Chemical and Physical Properties
Molecular Weight 161.65 g/mol
Molecular Formula C6H8ClNS
XLogP32.1
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass161.0065981 g/mol
Monoisotopic Mass161.0065981 g/mol
Topological Polar Surface Area41.1 Ų
Heavy Atom Count9
Formal Charge0
Complexity89.1
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in strokes.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Anticonvulsants

Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)


Neuroprotective Agents

Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)


GABA Modulators

Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)


Hypnotics and Sedatives

Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)


5.2 ATC Code

N - Nervous system

N05 - Psycholeptics

N05C - Hypnotics and sedatives

N05CM - Other hypnotics and sedatives

N05CM02 - Clomethiazole


5.3 Metabolism/Metabolites

Clomethiazole has known human metabolites that include NLA-715.

S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560


5.4 Mechanism of Action

clomethiazole interacts with the GABAA receptor complex. It inhibits the binding of [35S]butyl-bicyclophosphorothionate (TBPS), an effect indicative of GABAA receptor-channel activation, by increasing the rate of [35S]TBPS dissociation and decreasing the binding affinity. Gamma-aminobutyric acid (GABA), acting at GABAA receptors, is the main fast inhibitory neurotransmitter in mammalian central nervous system


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Global Sales Information

Do you need Business Intel? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty